CASI Pharmaceuticals
CASI
#10178
Rank
A$25.81 M
Marketcap
A$1.26
Share price
-3.74%
Change (1 day)
-68.17%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): A-$4.22

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$3.91. In 2024 the company made an earnings per share (EPS) of A-$3.61 a decrease over its 2023 EPS that were of A-$2.85.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$4.2216.86%
2024A-$3.6126.73%
2023A-$2.85-32.89%
2022A-$4.2511.9%
2021A-$3.80-38.44%
2020A-$6.17-8.96%
2019A-$6.7750%
2018A-$4.5277.78%
2017A-$2.545.88%
2016A-$2.40-22.73%
2015A-$3.10-76.09%
2014A-$12.98318.18%
2013A-$3.10-71.79%
2012A-$11.0165.96%
2011A-$6.63-50%
2010A-$13.27-18.97%
2009A-$16.37-63.64%
2008A-$45.023.57%
2007A-$43.47-60.56%
2006A-$110.2197.22%
2005A-$55.88-2.7%
2004A-$57.44-45.59%
2003A-$105.56-61.8%
2002A-$276.31-25.52%
2001A-$371.00-21.38%
2000A-$471.9113.86%
1999A-$414.47149.53%
1998A-$166.1098.15%
1997A-$83.8310.2%
1996A-$76.06